These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18787793)

  • 1. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin permeability of tulobuterol in two transdermal formulations and their followability.
    Takizawa Y; Goto T; Sato S; Ohmori N; Mori K; Shimada Y; Chen K; Miyagi T; Fukai F
    Drug Discov Ther; 2017 Nov; 11(5):253-258. PubMed ID: 29021505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tulobuterol crystal in transdermal patches using terahertz pulsed spectroscopy and imaging.
    Sakamoto T; Portieri A; Taday PF; Takada Y; Sasakura D; Aida K; Matsubara T; Miura T; Terahara T; Arnone DD; Kawanishi T; Hiyama Y
    Pharmazie; 2009 Jun; 64(6):361-5. PubMed ID: 19618670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
    Nan L; Song H; Wang H; Mi R; Wang X; Fang L
    Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Drug-in-Adhesive Patch with a Honeycomb Film as a Backing Layer.
    Suzuki T; Sakisako Y; Kurihara Y; Aoki T; Kanematsu T; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2018; 66(9):851-858. PubMed ID: 30175741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of marketed transdermal delivery systems for tulobuterol.
    Tojo K; Hikima T
    Biol Pharm Bull; 2007 Aug; 30(8):1576-9. PubMed ID: 17666825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adhesives and permeation enhancers on the skin permeation of captopril.
    Park ES; Chang SJ; Rhee YS; Chi SC
    Drug Dev Ind Pharm; 2001 Oct; 27(9):975-80. PubMed ID: 11763476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation.
    Uematsu T; Nakano M; Kosuge K; Kanamaru M; Nakashima M
    Eur J Clin Pharmacol; 1993; 44(4):361-4. PubMed ID: 8099880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
    Subedi RK; Ryoo JP; Moon C; Choi HK
    Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of ion-pair releasing from acrylic pressure sensitive adhesive containing carboxyl group: Roles of doubly ionic hydrogen bond in the controlled release process of bisoprolol ion-pair.
    Zhao H; Liu C; Yang D; Wan X; Shang R; Quan P; Fang L
    J Control Release; 2018 Nov; 289():146-157. PubMed ID: 30268589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
    Yoshihara S; Fukuda H; Abe T; Arisaka O
    Biol Pharm Bull; 2010; 33(10):1763-5. PubMed ID: 20930390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
    Park CW; Son DD; Kim JY; Oh TO; Ha JM; Rhee YS; Park ES
    Int J Pharm; 2012 Oct; 436(1-2):32-40. PubMed ID: 22771734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma.
    Iikura Y; Uchiyama H; Akimoto K; Ebisawa M; Sakaguchi N; Tsubaki T; Ishizu H; Kabayama H; Yagi K; Miura K
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):147-51. PubMed ID: 7697473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
    Soler LI; Boix A; Lauroba J; Colom H; Domenech J
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Biol Pharm Bull; 2012; 35(3):321-8. PubMed ID: 22382317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold Flow Evaluation in Transdermal Drug Delivery Systems by Measuring the Width of the Oozed Adhesive.
    Miyazaki T; Kanno H; Yamamoto E; Ando D; Izutsu KI; Goda Y
    AAPS PharmSciTech; 2020 Apr; 21(4):120. PubMed ID: 32323091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect and pharmacokinetics of ketotifen transdermal delivery system.
    Chiang CH; Chen JL; Liu YT; Wang DP
    Drug Dev Ind Pharm; 1998 Mar; 24(3):213-7. PubMed ID: 9876577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-month inhalation toxicity study of tulobuterol hydrochloride in rats and dogs.
    Dudley RE; Patterson SE; Machotka SV; Kesterson JW
    Fundam Appl Toxicol; 1989 Nov; 13(4):694-701. PubMed ID: 2576008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.